Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

1.92
-0.1000-4.95%
Post-market: 1.89-0.0300-1.56%17:26 EST
Volume:309.21K
Turnover:600.13K
Market Cap:108.49M
PE:-0.92
High:2.04
Open:2.04
Low:1.87
Close:2.02
Loading ...

BRIEF-TScan Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million

Reuters
·
5 hours ago

TScan Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS
·
6 hours ago

TScan Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
10 hours ago

TScan Therapeutics Inc : Needham Cuts Target Price to $9 From $11

THOMSON REUTERS
·
Yesterday

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
Yesterday

TScan Therapeutics Q4 2024 GAAP EPS $(0.30) Misses $(0.27) Estimate, Sales $665.00K Miss $1.35M Estimate, Cash, Cash Equivalents, And Marketable Securities Of $290.1M To Fund Operations Into Q1 Of 2027

Benzinga
·
Yesterday

BRIEF-TScan Therapeutics Q4 Net Income USD -35.809 Million

Reuters
·
Yesterday

TScan Therapeutics Q4 Collaboration and License Revenue USD 665 Thousand

THOMSON REUTERS
·
Yesterday

TScan Therapeutics Inc: Cash, Cash Equivalents, and Marketable Securities Continue to Fund Operations Into Q1 2027

THOMSON REUTERS
·
Yesterday

TScan Therapeutics Q4 Operating Expenses USD 37.377 Million

THOMSON REUTERS
·
Yesterday

TScan Therapeutics Q4 Net Income USD -35.809 Million

THOMSON REUTERS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
27 Feb

TScan Therapeutics Insider Ups Holding By 18% During Year

Simply Wall St.
·
05 Feb

Barclays Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
16 Jan

Here's Why TScan Therapeutics (TCRX) is Poised for a Turnaround After Losing -5.63% in 4 Weeks

Zacks
·
10 Jan